JSC,, Vian"

Kutaisi 4600

2 studies enrolling now · 4 studies all time

What they study most

MF, Marginal Zone Lymphoma, Melanoma, Myelofibrosis, Non-small Cell Lung Cancer, Post-ET Myelofibrosis, Post-PV MF, Primary Myelofibrosis, Relapsed/Refractory Follicular Lymphoma, Renal Cell Carcinoma, Ulcerative Proctitis

Studies at this site

• A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors — Recruiting now
• Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib — Recruiting now
• Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories — Completed
• A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling